Skip to main content

Table 1 Personal and medical data of the study participants

From: Level of asthma control and mental health of asthma patients during lockdown for COVID-19: a cross-sectional survey

Item

N (%)

Age (Mean ± SD)

36.05 ± 12.9 (range 12–78 years)

Gender

 Male

106 (40.2)

 Female

158 (59.8)

Comorbidities

 Nasal allergy

176 (66.7)

 Food allergy

33 (12.5)

 Diabetes

21 (8)

 Hypertension

19 (7.2)

 Medication allergy

17 (6.4)

 Others

33 (12.5)

Smoking

 Current smoker

21 (8)

 Former smoker

35 (13.3)

 Never smoked

208 (78.8)

Exposure to passive smoke

85 (32.2)

Exposure to home allergen

150 (56.8)

Pet exposure at home

58 (22)

Mold exposure at home

24 (9.1)

Mold exposure at home

24 (9.1)

Pattern of symptoms

 Seasonal

124 (47)

 All year long

43 (16.3)

 All year long, with seasonal worsening

97 (36.7)

Frequency of symptoms

 Twice or less weekly

90 (34.1)

 3–6 times weekly

56 (21.2)

 Once a day

47 (17.8)

 Throughout the day

71 (26.9)

Worsened symptoms

 Outdoors

37 (14)

 Indoors

70 (26.5)

 No difference

157 (59.5)

Presenting symptoms

 Shortness of breath

190 (72)

 Wheezes

103 (39)

 Chronic cough

80(30.3)

 Chest tightness

68 (25.8)

Asthma control test

 Poorly controlled

183 (69.3)

 Controlled

67 (25.4)

 Completely controlled

14 (5.3)

Duration of bronchial asthma illness (mean ± SD in years)

12.66 ± 11.78 (0.1–58)